Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: MabVax Therapeutics, Inc. (0) Acquired (5)
carboplatin (paraplatin) (2 trials)
doxorubicin (Doxil) (3 trials)
gefitinib (iressa) (1 trial)
tlk286 (13 trials)
topotecan (hycamtin) (1 trial)
Key: MabVax Therapeutics, Inc. (2) Acquired (4)
cisplatin (platinol) (1 trial)
docetaxel (taxotere) (1 trial)
gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester (8 trials)
paclitaxel (taxol) (1 trial)
saponin (1 trial)
trivalent ganglioside vaccine (1 trial)
Key: MabVax Therapeutics, Inc. (3) Acquired (1)
lenalidomide (revlimid) (1 trial)
mvt-1075 (1 trial)
mvt-2163 (1 trial)
mvt-5873 (2 trials)
Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Sarcoma (Phase 2)
Trials (25 total)
Trial APIs (15 total)